Related Experiment Video

Updated: Jun 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on

Lawrence A Notaro1, Mohammed H Usman, James F Burke

  • 1Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA.

Cardiovascular Therapeutics
|August 20, 2009
PubMed

Insights

Managing patients with coronary artery disease (CAD), cerebrovascular disease (CVD), and chronic kidney disease (CKD) requires unified guidelines. This review proposes optimal treatment strategies for these complex cases, emphasizing ACE inhibitors and statin therapy.

Area of Science:

  • Cardiology
  • Neurology
  • Nephrology

Background:

  • Coronary artery disease (CAD) frequently coexists with cerebrovascular disease (CVD) and chronic kidney disease (CKD).
  • Management is complex due to a lack of unified guidelines for patients with all three conditions.
  • Optimal treatment strategies are needed for this high-risk patient population.

Purpose of the Study:

  • To review current literature on managing patients with concurrent CAD, CVD, and CKD.
  • To propose an optimal, unifying treatment regimen for these complex cases.
  • To provide evidence-based recommendations for medication use and secondary prevention.

Main Methods:

  • Literature review of current studies and guidelines.
  • Synthesis of evidence regarding pharmacotherapy for patients with CAD, CVD, and CKD.
  • Development of a proposed optimal treatment algorithm.

Main Results:

  • Universal administration of angiotensin-converting enzyme inhibitors (ACE-I) is recommended.
  • High-dose statin therapy targeting LDL 70-100 mg/dL is advocated, with caution for patients with cerebral bleeding history.
  • Specific recommendations for beta-blockers, amlodipine/thiazide diuretics, and antiplatelet/anticoagulant therapies based on clinical events (stroke, ACS).

Conclusions:

  • A comprehensive management approach integrating cardiovascular, cerebrovascular, and renal considerations is essential.
  • Specific pharmacotherapies like ACE-I, statins, beta-blockers, and antiplatelets play crucial roles in secondary prevention.
  • Further research is needed to validate treatment strategies, particularly regarding dual antiplatelet therapy in CKD patients with ACS.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...